Axe Compute (AGPU) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for November 25, 2025, with five key proposals for shareholder vote, including director elections, auditor ratification, equity plan amendment, warrant issuance, and executive compensation advisory vote.
Shareholders of record as of October 24, 2025, are eligible to vote in person or by proxy, with detailed instructions provided for both record and beneficial owners.
Proxy solicitation is managed by Sodali & Co. for a fee of $15,000, with all solicitation costs borne by the company.
Voting matters and shareholder proposals
Election of two Class I directors for terms expiring at the 2028 Annual Meeting.
Ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2025.
Approval of an amendment to the 2024 Equity Incentive Plan to increase authorized shares from 66,667 to 1,066,667 and set a 500,000 share cap for incentive stock options.
Approval of issuance of 14,903,393 shares upon exercise of pre-funded warrants, as required by Nasdaq rules.
Advisory vote on executive compensation (say-on-pay).
Deadlines for 2026 shareholder proposals and director nominations are between August 27 and September 25, 2026.
Board of directors and corporate governance
Board consists of seven directors divided into three classes, with annual elections for one class; no term limits.
Recent changes include resignation of one director and appointment of a new Class II director.
Majority of directors are independent per Nasdaq standards; lead independent director role established.
Four standing committees: Audit, Compensation, Nominating and Governance, and Merger & Acquisition; all committee members are independent.
Cryptocurrency Subcommittee guides digital asset treasury strategy.
Code of Ethics and Recoupment Policy adopted; insider trading policy in place.
Latest events from Axe Compute
- Q2 2024 saw a $3.2M loss, cost cuts, and new AI/ML partnerships amid going concern risks.AGPU
Q2 20241 Feb 2026 - Registering 1.98M shares for resale; proceeds from warrant exercises fund operations.AGPU
Registration Filing16 Dec 2025 - AI-driven oncology firm shifts capital to Aethir tokens, heightening volatility and regulatory risk.AGPU
Registration Filing16 Dec 2025 - AI oncology and ATH-focused treasury strategy drive growth amid high digital asset risk.AGPU
Registration Filing16 Dec 2025 - AI-driven oncology and ATH-focused treasury strategy create high growth and risk exposure.AGPU
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify KPMG, and approve a new equity incentive plan.AGPU
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, auditor ratification, equity plan, and compensation.AGPU
Proxy Filing2 Dec 2025 - Votes sought for reverse split, $10M equity issuance, and adjournment to maintain Nasdaq listing.AGPU
Proxy Filing2 Dec 2025 - Vote on reverse split and new equity issuance to maintain Nasdaq listing and financial flexibility.AGPU
Proxy Filing2 Dec 2025